Q32 Bio
QTTB
QTTB
109 hedge funds and large institutions have $273M invested in Q32 Bio in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
20% less capital invested
Capital invested by funds: $343M → $273M (-$70.1M)
52% less call options, than puts
Call options by funds: $806K | Put options by funds: $1.69M
Holders
109
Holding in Top 10
2
Calls
$806K
Puts
$1.69M
Top Buyers
| 1 | +$6.64M | |
| 2 | +$3.68M | |
| 3 | +$1.27M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.07M |
| 5 |
BlackRock
New York
|
+$960K |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$8.98M | |
| 3 | -$4.02M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$938K |
| 5 |
Morgan Stanley
New York
|
-$894K |